Incorporation of native HCV E1E2 into a nanoparticle vaccine platform
Liudmila Kulakova, Sarah Jeong, Dong-Xiu Zhang, Xiaoran Shang, Kinlin L. Chao, Alexander Marin, Matthew C. Metcalf, Tagide deCarvalho, Edwin Pozharski, Yuxing Li, Brian G. Pierce, Alexander K. Andrianov, Eric A. Toth, Thomas R. Fuerst
This paper develops a nanoparticle vaccine platform incorporating native HCV E1E2 to enhance immunogenicity, showing improved neutralizing antibody responses compared to subunit vaccines.
bioRxiv · Aug 6, 2026 · PreprintMicrobiology